ArticleThe Milbank quarterly2023
The Future of the United States Overdose Crisis: Challenges and Opportunities.
Article in The Milbank quarterly, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 20 citations in OpenAlex.
- Provision of recommended treatment for stimulant use disorder in United States substance use treatment facilities.The International journal on drug policy · 2026Article
- Concurrent Use of Extra-Medical Medication for Opioid Use Disorder Among Adults Prescribed Methadone or Buprenorphine: A Cohort Study of Urban Adults Who Have Injected Drugs.Drug and alcohol review · 2026Article
- Impact of State Telemedicine Policies on Substance Use Disorder Treatment During the COVID-19 Pandemic.Journal of general internal medicine · 2026Article
- Travel Time to Methadone Treatment Via Personal Vehicle vs Public Transit.JAMA network open · 2026Article
- Nurse Practitioner Conceptions of Capability Providing Medication and Safe Supply for Opioid Use Disorder in Primary Care: A Phenomenographic Study.Journal of advanced nursing · 2025Article
- Harm reduction self-efficacy and motivations for contactless supply access among a sample of syringe services program participants.Harm reduction journal · 2025Article
- Challenges and recommendations for overdose prevention and harm reduction in an era of fentanyl and xylazine: Perspectives of women with opioid use disorder and professionals.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2024Article
- "Politics Versus Policy": Qualitative Insights on Stigma and Overdose Prevention Center Policymaking in the United States.Substance use & addiction journal · 2024Article
- The Legal Landscape for Opioid Treatment Agreements.The Milbank quarterly · 2024Article
- Enhancing drug checking services for supply monitoring: perspectives on implementation in syringe service programs in the USA.Harm reduction journal · 2024Review
- A Quantitative Examination of Illness Models Among People With Opioid Use Disorder Receiving Methadone Treatment.Journal of addiction medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Policy Points People are dying at record numbers from overdose in the United States. Concerted action has led to a number of successes, including reduced inappropriate opioid prescribing and increased availability of opioid use disorder treatment and harm-reduction efforts, yet ongoing challenges include criminalization of drug use and regulatory and stigma barriers to expansion of treatment and harm-reduction services. Priorities for action include investing in evidence-based and compassionate policies and programs that address sources of opioid demand, decriminalizing drug use and drug paraphernalia, enacting policies to make medication for opioid use disorder more accessible, and promoting drug checking and safe drug supply.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.